Skip to content

BBNX BBNX Common stock issuance for private placement

Common stock issuance for private placement at other companies

Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
$15.59M
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$0-100%
Barnes & Noble Education logo
Barnes & Noble EducationBNED
$0
KBO
Karbon Capital Partners Corp. Class A Ordinary SharesKBON
$8.9M
Vor Biopharma logo
Vor BiopharmaVOR
$75M
Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$0-100%

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's common stock issuance for private placement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's common stock issuance for private placement?
BBNX (BBNX) reported common stock issuance for private placement of $15.59M in Q1 2025.
What does common stock issuance for private placement mean?
This represents the cash inflows generated from the sale of equity securities to a select group of private investors rather than through a public offering. It serves as a measure of the company's ability to raise capital outside of public markets to fund operations or growth.